Treatment Trends 2017 for Neuro-Oncology include Checkpoint Inhibitors and Combination Therapy

Treatment Trends 2017 for Neuro-Oncology include Checkpoint Inhibitors and Combination Therapy

aacr2017

3 years
351 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Michael Ciesielski, PhD of Roswell Park Cancer Institute discusses the treatment trends in 2017 for his field, neuro-oncology, which include more use of checkpoint inhibitors and combination therapies. This was recorded at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
Up Next Autoplay